Yiyu Qin

1.0k total citations
43 papers, 819 citations indexed

About

Yiyu Qin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yiyu Qin has authored 43 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Yiyu Qin's work include Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yiyu Qin is often cited by papers focused on Cancer-related molecular mechanisms research (13 papers), RNA modifications and cancer (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yiyu Qin collaborates with scholars based in China, Canada and United States. Yiyu Qin's co-authors include Wei Gong, Zhiwei Quan, Mingdi Zhang, Mingzhe Weng, Mingzhe Ma, Yan Zhang, Chunxiao Li, Zhaohui Tang, Xiang Kong and Jianguang Jia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Yiyu Qin

41 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiyu Qin China 16 606 519 121 117 63 43 819
Chung Wah Wu Hong Kong 13 633 1.0× 609 1.2× 87 0.7× 136 1.2× 85 1.3× 18 905
Hao Zheng China 19 730 1.2× 605 1.2× 81 0.7× 83 0.7× 49 0.8× 47 1.0k
Shicai Ye China 17 589 1.0× 508 1.0× 106 0.9× 106 0.9× 52 0.8× 40 917
Xiangliang Zhang China 15 412 0.7× 345 0.7× 121 1.0× 88 0.8× 108 1.7× 25 668
Mingsong Wang China 17 549 0.9× 284 0.5× 53 0.4× 106 0.9× 67 1.1× 33 761
Qi Shen China 17 707 1.2× 534 1.0× 61 0.5× 113 1.0× 85 1.3× 41 1.1k
Xiquan Ke China 16 547 0.9× 472 0.9× 93 0.8× 189 1.6× 79 1.3× 33 855
Xiaohua Zhang China 15 508 0.8× 401 0.8× 44 0.4× 139 1.2× 43 0.7× 34 732
Keqiang Yan China 17 599 1.0× 471 0.9× 198 1.6× 83 0.7× 39 0.6× 29 912

Countries citing papers authored by Yiyu Qin

Since Specialization
Citations

This map shows the geographic impact of Yiyu Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiyu Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiyu Qin more than expected).

Fields of papers citing papers by Yiyu Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiyu Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiyu Qin. The network helps show where Yiyu Qin may publish in the future.

Co-authorship network of co-authors of Yiyu Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Yiyu Qin. A scholar is included among the top collaborators of Yiyu Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiyu Qin. Yiyu Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Hongyan, Lihu Zhang, Chuntao Wang, et al.. (2023). Network Pharmacology Analysis and Experimental Verification on Antiangiogenesis Mechanism of Hedyotis diffusa Willd in Liver Cancer. Evidence-based Complementary and Alternative Medicine. 2023(1). 1416841–1416841. 5 indexed citations
3.
Huang, Yan, et al.. (2023). A novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway. Chinese Medicine. 18(1). 72–72. 2 indexed citations
4.
Qin, Yiyu, et al.. (2021). Knockdown of circSMAD2 inhibits the tumorigenesis of gallbladder cancer through binding with eIF4A3. BMC Cancer. 21(1). 1172–1172. 4 indexed citations
5.
Qin, Yiyu, et al.. (2020). <p>Downregulation of miR-575 Inhibits the Tumorigenesis of Gallbladder Cancer via Targeting p27 Kip1</p>. OncoTargets and Therapy. Volume 13. 3667–3676. 9 indexed citations
6.
Yang, Yan, et al.. (2020). Tissue factor pathway inhibitor 2 suppresses the growth of thyroid cancer cells through by induction of apoptosis. Asia-Pacific Journal of Clinical Oncology. 17(2). e48–e56. 7 indexed citations
7.
Fu, Yang, Ge Yang, Yang Yu, et al.. (2019). Small nucleolar RNA host gene 1 promotes development and progression of colorectal cancer through negative regulation of miR‐137. Molecular Carcinogenesis. 58(11). 2104–2117. 22 indexed citations
8.
Deng, Min, Yiyu Qin, Xiaohong Chen, Qizhi Wang, & Jianchao Wang. (2019). <p>MiR&ndash;206 inhibits proliferation, migration, and invasion of gastric cancer cells by targeting the <em>MUC1</em> gene</p>. OncoTargets and Therapy. Volume 12. 849–859. 36 indexed citations
9.
Qin, Yiyu, et al.. (2019). Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo. Biomedicine & Pharmacotherapy. 118. 109266–109266. 9 indexed citations
11.
Zhang, Mingdi, Yiyu Qin, Bin Zuo, et al.. (2017). Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression. PLoS ONE. 12(2). e0167782–e0167782. 11 indexed citations
12.
Zhang, Mingdi, Shizhong Cai, Bin Zuo, et al.. (2017). Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway. Tumor Biology. 39(5). 3726131435–3726131435. 27 indexed citations
13.
Qin, Yiyu, Meng Li, Yang Fu, et al.. (2017). SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling. Oncotarget. 8(12). 19980–19996. 24 indexed citations
14.
Ma, Mingzhe, Yan Zhang, Mingzhe Weng, et al.. (2016). Long Noncoding RNA GCASPC , a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer. Cancer Research. 76(18). 5361–5371. 77 indexed citations
15.
Jia, Jianguang, Yiyu Qin, Ligong Zhang, et al.. (2016). Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis. Molecular Medicine Reports. 13(5). 4461–4468. 50 indexed citations
16.
Guo, Runsheng, et al.. (2016). IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncology Letters. 12(6). 4749–4755. 6 indexed citations
17.
Ma, Mingzhe, Mingzhe Weng, Mingdi Zhang, et al.. (2015). Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.. PubMed. 8(2). 1822–5. 5 indexed citations
18.
Ma, Mingzhe, Xiang Kong, Mingzhe Weng, et al.. (2014). Long non‐coding RNA‐LET is a positive prognostic factor and exhibits tumor‐suppressive activity in gallbladder cancer. Molecular Carcinogenesis. 54(11). 1397–1406. 60 indexed citations
19.
Weng, Mingzhe, Mingdi Zhang, Yiyu Qin, et al.. (2014). Targeting gallbladder carcinoma: bone marrow-derived stem cells as therapeutic delivery vehicles of myxoma virus. Chinese Medical Journal. 127(12). 2350–2356. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026